Jill  Anderson net worth and biography

Jill Anderson Biography and Net Worth

Director Since: January 2019
Committees: Finance; Operating
Other Public Boards: None
Education: B.A. (finance), Temple University; M.B.A., Temple University

Career Highlights
– President, Chief Executive Officer and Director of Cianna Medical from January 2008 until the Company’s acquisition of Cianna Medical in November 2018
– President of BioLucent, Inc. from May 2001 to September 2007
– Previously served on the Board of Directors for Mammoplan LLC, and Solis Women’s Health

Qualifications of Particular Relevance to Merit
Ms. Anderson is a healthcare executive with more than 18 years of experience leading the innovation, development and commercialization of medical devices. The Board believes she brings innovative thinking and creative problem solving to addressing complex business problems in the search for growth opportunities. Ms. Anderson is skilled in building executive-level teams, commercializing breakthrough technologies, strategic planning, market strategy, company and product branding, marketing and communications. Her entrepreneurial nature and commitment to patient care has contributed to the development and successful exit of two venture-backed medical device companies and the organization and operation of several for-profit and not-for-profit comprehensive cancer centers.

How do I contact Jill Anderson?

The corporate mailing address for Ms. Anderson and other Merit Medical Systems executives is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. Merit Medical Systems can also be reached via phone at (801) 253-1600 and via email at [email protected]. Learn More on Jill Anderson's contact information.

Has Jill Anderson been buying or selling shares of Merit Medical Systems?

Jill Anderson has not been actively trading shares of Merit Medical Systems during the last ninety days. Most recently, Jill Anderson sold 850 shares of the business's stock in a transaction on Friday, September 10th. The shares were sold at an average price of $71.64, for a transaction totalling $60,894.00. Learn More on Jill Anderson's trading history.

Who are Merit Medical Systems' active insiders?

Merit Medical Systems' insider roster includes A. Anderson (Director), Jill Anderson (Director), David Floyd (Director), Ronald Frost (COO), Thomas Gunderson (Director), Fred Lampropoulos (Founder, Chairman and CEO), Brian Lloyd (Insider), F. Millner (Director), Raul Parra, Jr. (CFO), Neil Peterson (COO), Michel Voigt (Insider), Lynne Ward (Director), and Joseph Wright (Insider). Learn More on Merit Medical Systems' active insiders.

Are insiders buying or selling shares of Merit Medical Systems?

In the last twelve months, insiders at the medical instruments supplier sold shares 8 times. They sold a total of 131,783 shares worth more than $11,203,323.63. The most recent insider tranaction occured on November, 15th when Director F. Ann Millner sold 12,500 shares worth more than $1,269,375.00. Insiders at Merit Medical Systems own 3.7% of the company. Learn More about insider trades at Merit Medical Systems.

Information on this page was last updated on 11/15/2024.

Jill Anderson Insider Trading History at Merit Medical Systems

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2021Sell850$71.64$60,894.00View SEC Filing Icon  
See Full Table

Jill Anderson Buying and Selling Activity at Merit Medical Systems

This chart shows Jill Anderson's buying and selling at Merit Medical Systems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Merit Medical Systems Company Overview

Merit Medical Systems logo
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
Read More

Today's Range

Now: $105.06
Low: $103.97
High: $105.13

50 Day Range

MA: $98.23
Low: $93.76
High: $104.71

2 Week Range

Now: $105.06
Low: $65.46
High: $105.46

Volume

50,336 shs

Average Volume

437,974 shs

Market Capitalization

$6.12 billion

P/E Ratio

51.50

Dividend Yield

N/A

Beta

0.89